首站-论文投稿智能助手
典型文献
Tenglong Buzhong granules(藤龙补中颗粒)inhibits the growth of SW620 human colon cancer in vivo
文献摘要:
OBJECTIVE:To observe the anticancer effects of the granular preparation of Tenglong Buzhong decoction(藤龙补中汤,TBD),i.e Tenglong Buzhong granules(藤龙补中颗粒,TBG),in human SW620 colon cancer.METHODS:BALB/c nude mice were subcutaneously transplanted with SW620 cells,and treated with TBG(2.56 g/kg,once per day)and/or 5-Fu(104 mg/kg,once per week)for 21 d.Apoptosis,Caspase activities and cellular senescence were measured by commercial kits.The protein expression and phosphorylation were detected by Western blot or immunohistochemistry.RESULTS:TBG and 5-Fu inhibited tumor growth.The tumor inhibition rate of the TBG,5-Fu,and TBG+5-Fu groups was 42.25%,51.58%,and 76.08%,respectively.Combination of TBG and 5-Fu showed synergetic anti-cancer effects.TBG and 5-Fu induced apoptosis,activated caspase-3,-8,and-9,increased SMAC expression,inhibited XIAP expression.TBG induced cellular senescence,upregulated cyclin-dependent kinase inhibitor 1a(CDKN1a)and cyclin-dependent kinase inhibitor 2a(CDKN2a)expression,and inhibited phosphorylation of retinoblastoma-associated protein(RB)and expression of cyclin E1(CCNE1)and cyclin-dependent kinases(CDK)2.TBG also inhibited angiogenesis accompanied by downregulation of vascular endothelial growth factor(VEGF)and hypoxia-inducible factor-1α(HIF-1α).CONCLUSIONS:TBG inhibits SW620 colon cancer growth,induces apoptosis via SMAC-XIAP-Caspases signaling,induces cellular senescence through CDKN1a/CDKN2a-RB-E2F signaling,inhibits angiogenesis by down-regulation of HIF-1α and VEGF,and enhances the effects of 5-Fu.
文献关键词:
作者姓名:
LI Miao;ZHENG Jialu;WANG Shuangshuang;CHEN Lei;PENG Xiao;CHEN Jinfang;AN Hongmei;HU Bing
作者机构:
Institute of Traditional Chinese Medicine in Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Science and Technology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
引用格式:
[1]LI Miao;ZHENG Jialu;WANG Shuangshuang;CHEN Lei;PENG Xiao;CHEN Jinfang;AN Hongmei;HU Bing-.Tenglong Buzhong granules(藤龙补中颗粒)inhibits the growth of SW620 human colon cancer in vivo)[J].中医杂志(英文版),2022(05):701-706
A类:
Tenglong,Buzhong,TBG+5,CDKN1a,CDKN2a
B类:
granules,inhibits,growth,SW620,human,colon,vivo,OBJECTIVE,To,observe,anticancer,effects,granular,preparation,decoction,TBD,METHODS,BALB,nude,mice,were,subcutaneously,transplanted,cells,treated,once,per,day,Fu,week,Apoptosis,activities,cellular,senescence,measured,by,commercial,kits,protein,expression,phosphorylation,detected,blot,immunohistochemistry,RESULTS,inhibited,tumor,inhibition,rate,groups,was,respectively,Combination,showed,synergetic,induced,apoptosis,activated,caspase,increased,SMAC,XIAP,upregulated,cyclin,dependent,inhibitor,retinoblastoma,associated,RB,CCNE1,kinases,also,angiogenesis,accompanied,downregulation,vascular,endothelial,VEGF,hypoxia,inducible,HIF,CONCLUSIONS,induces,via,Caspases,signaling,through,E2F,enhances
AB值:
0.43509
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway
Shuai-xing Wang;Ye-nan Feng;Shan Feng;Ji-min Wu;Mi Zhang;Wen-li Xu;You-yi Zhang;Hai-bo Zhu;Han Xiao;Er-dan Dong-Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital,NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;State Key Laboratory for Bioactive Substances and Functions of Natural Medicines,Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。